Work

TACE combined with the intra-arterial infusion of bevacizumab for BCLC-stage B hepatocellular carcinoma beyond up-to-seven criteria: A prospective, single-arm, phase II study.

Year: 2025

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e16302

Authors: Fei Gao, Li-jie Qiu, Yu-Zhe Cao, Xiaobo Fu, Maoyuan Mu, Zixiong Chen, Han Qi

Institutions: Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410812904

FWCI:

Cites:

Cited by:

Related to: 10